Effector mechanisms by which adoptively transferred T cells promote tumor eradication.
D000818:Animals; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D006649:Histocompatibility Antigens / Q000276:immunology; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007371:Interferon-gamma / Q000627:therapeutic use; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy / Q000628:therapy; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000628:therapy*; D008264:Macrophages / Q000276:immunology; D051379:Mice; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D007371:Interferon-gamma; D003520:Cyclophosphamide